'Magic potion' in fly spit may shoo away blinding eye disease

Apr 06, 2009
Scientists have found proteins in the black fly’s saliva that help spread parasites that cause a devastating eye disease. Credit: US Department of Agriculture, The Diptera Site

Researchers are reporting the first identification of a "magic potion" of proteins in the saliva of the black fly that help this blood-sucking pest spread parasites that cause "river blindness," a devastating eye-disease. A better understanding of these proteins may lead to better drugs and a vaccine for river blindness and other diseases spread by biting insects. Also known as onchocerciasis, river blindness affects more than 17 million people worldwide, particularly in rural Africa. The report appears in the current edition of ACS' Journal of Proteome Research.

In the new study, José M.C. Ribeiro and colleagues explain that the of adult female black flies contains substances that mute the human body's natural defenses. This chemical cocktail makes the body more vulnerable to disease when infected flies bite into the skin. Until now, however, nobody had identified the specific chemicals involved in this devious action.

The scientists collected salivary glands from hundreds of adult female black flies and isolated the proteins using high-tech analytical gear. They identified 72 different proteins, including several new to science. These proteins could serve as the basis for developing drugs or vaccines against diseases transmitted by the black fly and other blood-sucking insects, including mosquitoes, midges, and sand flies, the researchers say. - MTS

More information: "Insight into the Sialome of the Black Fly, Simulium vittatum, Journal of Proteome Research.

Provided by American Chemical Society (news : web)

Explore further: Breakthrough points to new drugs from nature

add to favorites email to friend print save as pdf

Related Stories

New drug resistance found in river blindness

Jun 15, 2007

A 20-year effort to control the spread of onchocerciasis, or river blindness, in African communities is threatened by the development of drug resistance in the parasite that causes the disease, a study by McGill University ...

Advance toward first saliva test for Type 2 diabetes

Jan 19, 2009

Scientists in Oregon and India are reporting an advance toward developing the first saliva test to diagnose and monitor effectiveness of treatment for Type 2 diabetes. Their report was published in the Jan. 2 issue of ACS' ...

Recommended for you

Breakthrough points to new drugs from nature

8 hours ago

Researchers at Griffith University's Eskitis Institute have developed a new technique for discovering natural compounds which could form the basis of novel therapeutic drugs.

World's first successful visualisation of key coenzyme

9 hours ago

Japanese researchers have successfully developed the world's first imaging method for visualising the behaviour of nicotine-adenine dinucleotide derivative (NAD(P)H), a key coenzyme, inside cells. This feat ...

User comments : 0

More news stories

Breakthrough points to new drugs from nature

Researchers at Griffith University's Eskitis Institute have developed a new technique for discovering natural compounds which could form the basis of novel therapeutic drugs.

A greener source of polyester—cork trees

On the scale of earth-friendly materials, you'd be hard pressed to find two that are farther apart than polyester (not at all) and cork (very). In an unexpected twist, however, scientists are figuring out ...

A beautiful, peculiar molecule

"Carbon is peculiar," said Nobel laureate Sir Harold Kroto. "More peculiar than you think." He was speaking to a standing-room-only audience that filled the Raytheon Amphitheater on Monday afternoon for the ...

Down's chromosome cause genome-wide disruption

The extra copy of Chromosome 21 that causes Down's syndrome throws a spanner into the workings of all the other chromosomes as well, said a study published Wednesday that surprised its authors.

IBM posts lower 1Q earnings amid hardware slump

IBM's first-quarter earnings fell and revenue came in below Wall Street's expectations amid an ongoing decline in its hardware business, one that was exasperated by weaker demand in China and emerging markets.